• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝血管活性肠肽受体的增溶。流体动力学特性及与功能性GTP调节蛋白相关联的证据。

Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.

作者信息

Couvineau A, Amiranoff B, Laburthe M

出版信息

J Biol Chem. 1986 Nov 5;261(31):14482-9.

PMID:3021741
Abstract

Vasoactive intestinal peptide (VIP) receptors were solubilized using the nondenaturing detergent Triton X-100 after occupancy of rat liver membrane-bound receptors with 125I-VIP. Gel filtration and ultracentrifugation on sucrose density gradients revealed the existence in the soluble macromolecular fraction of two labeled components: a major (80%) heavy component and a minor (20%) light one. The two components exhibit the following hydrodynamic parameters: Stokes radius, 5.8 nm: s20,w, 5.98 s; Mr, 150,000; frictional ratio, 1.52 for the major; and Stokes radius, 3.0 nm: s20,w, 3.98 s; Mr = 52,000; frictional ratio, 1.12 for the minor component. The labeling of these components was specific in that it dramatically decreased when unlabeled VIP was added together with 125I-VIP. The pharmacological specificity was also assessed by using 10 nM histidylisoleucineamide (a VIP agonist). Many lines of evidence indicate that the light component (Mr = 52,000) is the VIP-receptor complex while the heavy component (Mr = 150,000) is a ternary complex consisting of VIP, the receptor, and a guanine nucleotide regulatory protein, probably Ns. GTP is required to dissociate 125I-VIP from the heavy component whereas it is ineffective on the light component. This effect is nucleotide specific. After cholera toxin-induced [32P]ADP ribosylation of liver membranes, a high peak of 32P radioactivity containing the alpha subunit (Mr = 42,000) of the Ns protein is coeluted with the heavy component on Sephacryl S-300. By mild urea (2 M) treatment, the heavy component is converted into the light without significant dissociation of 125I-VIP. When a Triton extract of membranes prelabeled with 125I-VIP is treated with dithiobis(succinimidyl propionate) subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis reveals a major band corresponding to Mr = 150,000. Alternatively, when prelabeled membranes are directly treated with the cross-linker, a major complex of Mr = 51,000 is observed. This may be related to different accessibility of the cross-linker to the site at which the receptor and the Ns protein interact in the two conditions. In conclusion, these data represent initial reports on the successful solubilization of functional VIP-receptor complexes and provide evidence for an interaction between liver VIP-receptor complexes and a GTP-binding protein.

摘要

用非变性去污剂 Triton X-100 使血管活性肠肽(VIP)受体溶解,此前用 125I-VIP 占据大鼠肝细胞膜结合受体。凝胶过滤和蔗糖密度梯度超速离心显示,在可溶性大分子部分存在两种标记成分:一种主要的(80%)重成分和一种次要的(20%)轻成分。这两种成分具有以下流体动力学参数:主要成分的斯托克斯半径为 5.8 nm,沉降系数 s20,w 为 5.98 s,相对分子质量 Mr 为 150,000,摩擦比为 1.52;次要成分的斯托克斯半径为 3.0 nm,沉降系数 s20,w 为 3.98 s,Mr = 52,000,摩擦比为 1.12。这些成分的标记具有特异性,因为当未标记的 VIP 与 125I-VIP 一起添加时,标记显著减少。还使用 10 nM 组氨酰异亮氨酸酰胺(一种 VIP 激动剂)评估了药理学特异性。许多证据表明,轻成分(Mr = 52,000)是 VIP 受体复合物,而重成分(Mr = 150,000)是由 VIP、受体和鸟嘌呤核苷酸调节蛋白(可能是 Ns)组成的三元复合物。从重组分中解离 125I-VIP 需要 GTP,而对轻成分无效。这种作用是核苷酸特异性的。在霍乱毒素诱导肝细胞膜的[32P]ADP 核糖基化后,含有 Ns 蛋白α亚基(Mr = 42,000)的 32P 放射性高峰与重成分在 Sephacryl S-300 上共洗脱。通过温和的尿素(2 M)处理,重组分转化为轻组分,而 125I-VIP 没有明显解离。当用二硫代双(琥珀酰亚胺丙酸酯)处理预先用 125I-VIP 标记的膜的 Triton 提取物,随后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析时,显示出一条对应于 Mr = 150,000 的主要条带。或者,当预先标记的膜直接用交联剂处理时,观察到一个 Mr = 51,000 的主要复合物。这可能与两种条件下交联剂对受体和 Ns 蛋白相互作用位点的不同可及性有关。总之,这些数据代表了关于成功溶解功能性 VIP 受体复合物的初步报告,并为肝 VIP 受体复合物与 GTP 结合蛋白之间的相互作用提供了证据。

相似文献

1
Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.肝血管活性肠肽受体的增溶。流体动力学特性及与功能性GTP调节蛋白相关联的证据。
J Biol Chem. 1986 Nov 5;261(31):14482-9.
2
Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine.大鼠肠道中鸟嘌呤核苷酸敏感的血管活性肠肽受体复合物的增溶及流体动力学特性研究
Biochemistry. 1989 Feb 21;28(4):1667-72. doi: 10.1021/bi00430a036.
3
Functional and immunological evidence for stable association of solubilized vasoactive-intestinal-peptide receptor and stimulatory guanine-nucleotide-binding protein from rat liver.大鼠肝脏中可溶性血管活性肠肽受体与刺激性鸟嘌呤核苷酸结合蛋白稳定结合的功能和免疫学证据。
Eur J Biochem. 1990 Feb 14;187(3):605-9. doi: 10.1111/j.1432-1033.1990.tb15343.x.
4
Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.大鼠肺膜血管活性肠肽受体的特性鉴定与增溶
Endocrinology. 1987 Jun;120(6):2442-52. doi: 10.1210/endo-120-6-2442.
5
Evidence for the formation of a functional complex between vasoactive intestinal peptide, its receptor, and Gs in lung membranes.血管活性肠肽、其受体与Gs在肺膜中形成功能性复合物的证据。
J Biol Chem. 1992 Feb 15;267(5):3382-8.
6
Hydrodynamic characterization of vasoactive intestinal peptide receptors extracted from rat lung membranes in Triton X-100 and n-octyl-beta-D-glucopyranoside.
J Biol Chem. 1987 Nov 15;262(32):15740-5.
7
Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.从大鼠肝脏中增溶血管活性肠肽的活性及稳定受体。
Regul Pept. 1989 Apr;25(1):37-50. doi: 10.1016/0167-0115(89)90246-2.
8
Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.大鼠精囊血管活性肠肽受体的特性研究
Am J Physiol. 1991 Feb;260(2 Pt 1):E286-91. doi: 10.1152/ajpendo.1991.260.2.E286.
9
Vasoactive intestinal peptide receptor on liver plasma membranes: solubilization and cross-linking.肝细胞膜上的血管活性肠肽受体:增溶与交联
Peptides. 1990 Nov-Dec;11(6):1255-61. doi: 10.1016/0196-9781(90)90160-7.
10
The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.大鼠肝脏血管活性肠肽结合位点。通过共价交联进行分子特征分析及与肠道受体存在差异的证据。
Biochem J. 1985 Jan 15;225(2):473-9. doi: 10.1042/bj2250473.

引用本文的文献

1
Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.完整人结肠腺癌细胞系HT29-D4上血管活性肠肽结合位点的光亲和标记。光敏性血管活性肠肽衍生物的合成与应用。
Biochem J. 1988 Mar 15;250(3):679-85. doi: 10.1042/bj2500679.
2
Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.部分肝切除术后大鼠肝脏中的血管活性肠肽受体
Biochem J. 1992 Jul 15;285 ( Pt 2)(Pt 2):515-20. doi: 10.1042/bj2850515.